A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel.

about

A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel.

Item

http://www.wikidata.org/entity/Q55030434

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel.

@en

A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel.

@nl

type

Item

label

A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel.

@en

A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel.

@nl

prefLabel

A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel.

@en

A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel.

@nl

P1476

A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel.

@en

P2093

Bao-Hui Han

http://www.w3.org/2001/XMLSchema#string

Caicun Zhou

http://www.w3.org/2001/XMLSchema#string

Chang-Li Wang

http://www.w3.org/2001/XMLSchema#string

Chun-Dong Gu

http://www.w3.org/2001/XMLSchema#string

Ding Yu

http://www.w3.org/2001/XMLSchema#string

Fan Yang

http://www.w3.org/2001/XMLSchema#string

Gang Chen

http://www.w3.org/2001/XMLSchema#string

Gong-Yan Chen

http://www.w3.org/2001/XMLSchema#string

Guang-Ying Zhu

http://www.w3.org/2001/XMLSchema#string

Guanshan Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Liquid biopsies: genotyping circulating tumor DNA

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.

Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F.

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice

Circulating tumor DNA as a liquid biopsy for cancer.

Integrated digital error suppression for improved detection of circulating tumor DNA

Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy.

P304

e000174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ESMOOPEN-2017-000174

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yi-Long Wu

P577

2017-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28848676

http://www.w3.org/2001/XMLSchema#string

P921

biopsy

P932

5559904

http://www.w3.org/2001/XMLSchema#string